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Background: Since the recent introduction of radioimmunotherapy (RIT) using antibodies against cluster of differentiation (CD) 45 
for the treatment of lymphoma, the clinical significance of the CD45 antigen has been increasing steadily. Here, we analyzed CD45 
expression on lymphocyte subsets using flow cytometry in order to predict the susceptibility of normal lymphocytes to RIT. 
Methods: Peripheral blood specimens were collected from 14 healthy individuals aged 25-54 yr. The mean fluorescence intensity 
(MFI) of the cell surface antigens was measured using a FACSCanto II system (Becton Dickinson Bioscience, USA). MFI values were 
converted into antibody binding capacity values using a Quantum Simply Cellular microbead kit (Bangs Laboratories, Inc., USA). 
Results: Among the lymphocyte subsets, the expression of CD45 was the highest (725,368±42,763) on natural killer T (NKT) cells, 
674,030±48,187 on cytotoxic/suppressor T cells, 588,750±48,090 on natural killer (NK) cells, 580,211±29,168 on helper T (Th) cells, 
and 499,436±21,737 on B cells. The Th cells and NK cells expressed a similar level of CD45 (P=0.502). Forward scatter was the high-
est in NKT cells (P<0.05), whereas side scatter differed significantly between each of the lymphocyte subsets (P<0.05). CD3 ex-
pression was  highest in the Th and NKT cells. 
Conclusions: NKT cells express the highest levels of CD45 antigen. Therefore, this lymphocyte subset would be most profoundly 
affected by RIT or pretargeted RIT. The monitoring of this lymphocyte subset during and after RIT should prove helpful. 
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INTRODUCTION
Analysis of lymphocyte subsets via flow cytometry to 
measure the distribution of helper T (Th) cells, cytotoxic/
suppressor T (Ts) cells, B cells, and natural killer (NK) cells 
is widely employed for the diagnosis and follow-up of sev-
eral diseases [1]. Recently, quantitative analysis has become 
possible, as has the measurement of the relative ratios of 
lymphocyte subsets. 
Cluster of differentiation (CD) 45 is a cell surface glyco-
protein with a cytoplasmic tyrosine phosphatase domain 
that catalyzes the removal of phosphates from tyrosine resi-
dues in several substrates, and CD45 is believed to function 
in both the activation and suppression of lymphocytes as 
well as in T cell maturation [2, 3]. CD45 has previously been 
shown to play an important role in several diseases. A mu-
tation resulting in the elimination of CD45 expression in 
white blood cells is associated with the induction of severe 
combined immunodeficiency [4]. Reduced expression of 
CD45-protein-tyrosine phosphatase provides protection 
against anthrax pathogenesis [5]. Recently, radioimmuno-
therapy (RIT) using anti-CD45 antibodies has become 
more popular. In an effort to improve the efficacy of this 
treatment in lymphomas, studies on pretargeted RIT (PRIT) 
using biotin-labeled anti-CD45 antibodies prior to radio-
therapy with avidin-labeled radioisotopes are actively under 
way [6-9]. Because 85% to 95% of B-cell lymphoma and 
leukemic cells have relatively high numbers of CD45 (100-
300,000 antigenic sites per cell), CD45 can be used to im-Im M, et al.  •  CD45 Antigen on Lymphocyte Subsets
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prove RIT targeting of both leukemias and lymphomas [9]. 
However, normal cells that express more CD45 will be more 
affected by RIT. Although CD45 is expressed on almost all 
hematopoietic cells, lymphocytes could be more affected 
than other cells because lymphocytes express the largest 
quantities of CD45. The function of each lymphocyte subset 
is distinct, and it is possible to anticipate which subset would 
be influenced more profoundly by RIT using an anti-CD45 
antibody. However, neither the difference in the expression 
levels of CD45 antigen on each lymphocyte subset, nor the 
correlation between CD45 expression and other cellular 
characteristics, including the levels of additional surface an-
tigens, forward scatter (FSC), and side scatter (SSC) has 
been adequately studied. In this study, we measured the lev-
els of CD45 expression on lymphocyte subsets using flow 
cytometry, and analyzed the correlation between the afore-
mentioned factors to predict the susceptibility of normal 
lymphocytes to RIT. Quantitative analysis of the CD3 anti-
gen on the T cell subset was also analyzed.
MATERIALS AND METHODS
1. Blood samples
Peripheral blood samples (3 mL) from 14 healthy adults 
(5 males and 9 females; aged 25 to 54 yr; mean age, 31.4) 
were collected into dipotassium EDTA blood collection 
tubes (Becton Dickinson, Franklin Lakes, NJ, USA). The 
volunteers signed informed consent forms, and the study 
was approved by the institutional review board. Samples 
were stored at room temperature and processed within 2 hr 
after collection. A complete blood cell count and lympho-
cyte subsets test for all 14 individuals showed normal results 
(Table 1).
2. Comparative quantitative analysis of CD45 expression 
  on the leukocyte subpopulation and each lymphocyte 
  subset
Monoclonal antibodies conjugated with 4 different fluo-
rescent dyes-fluorescein isothiocyanate (FITC), phycoery-
thrin (PE), peridinin chlorophyll A protein (PerCP), and 
phycoerythrin-cyanine 7 (PE-CY7)-were used. In the first 
tube, 10 μL of monoclonal antibodies against CD4, CD8, 
CD3, and CD45 that were each labeled with a different fluo-
rescent dye were mixed with 100 μL of blood. In the second 
tube, 10 μL of monoclonal antibodies against CD3, CD19, 
CD56, and CD45 that were each labeled with a different 
fluorescent dye were mixed with 100 μL of blood. The tubes 
were left in a dark room for 15 min, and then lysed with 2 
mL of red blood cell lysing solution (Becton Dickinson) for 
15 min. After 2 washes with 3 mL of phosphate-buffered 
saline (PBS), the samples were resuspended in 1 mL of PBS. 
Ten thousand events per sample were analyzed and ac-
quired with a flow cytometer (FACSCanto II, Becton Dick-
inson Bioscience, San Jose, CA, USA). Lymphocytes, granu-
locytes, and monocytes were gated with CD45 and SSC 
(Fig. 2A). Lymphocyte subsets were classified as follows: 
Table 1. The percentage of each lymphocyte subset in 14 healthy individuals
No. Case NKT (%) NK (%) Ts (%) Th (%) B (%)
1 6.5 20.5 23.3 33.8 12.5
2 2.4  8.8 20.5 42.9 21.4
3 7.0 10.8 42.3 32.4  8.4
4 4.2 18.3 21.5 38.6 17.4
5 9.8 14.8 26.4 36.5 15.4
6 4.1 18.2 16.3 43.6 12.8
7 4.0 14.4 27.5 38.1 15.2
8 16.8  9.5 21.1 35.7 16.0
9 5.3  5.7 22.8 39.1 29.2
10 10.3 16.0 22.5 36.3 14.5
11 2.9 23.1 16.6 44.1 13.2
12 7.0 12.5 35.1 25.6 21.3
13 4.0 29.7 25.2 29.2 13.0
14 2.9 22.3 20.3 39.1 14.9
Abbreviations: NKT, natural killer T cell; NK, natural killer cell; Ts, cytotoxic/suppressor 
T cell; Th, helper T cell; B, B cell.
Fig. 1. Calibration curve of CD45 phycoerythrin-cyanine 7.
Abbreviations: MESF, molecules of equivalent soluble fluorochromes; ABC, 
antibody-binding capacity.
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CD3+CD4+ Th cells, CD3+CD8+ Ts cells, CD19+ B cells, 
CD3-CD56+ NK cells, and CD3+CD56+ natural killer T 
(NKT) cells. The mean FSC and SSC values were obtained 
for each cell population. The mean fluorescence intensity 
(MFI) value for each antigen expressed on each cell popula-
tion was obtained using BD FACSDiva software (Becton 
Dickinson Bioscience). The MFI values were converted into 
antibody-binding capacity (ABC) values using a Quantum 
Simply Cellular anti-Mouse IgG Kit (Bangs Laboratories, 
Inc., Fishers, IN, USA). This is a mixture of 5 microbead 
populations of uniform size, coated with known amounts of 
goat anti-mouse immunoglobulin G. One drop of each mi-
crobead suspension was mixed with 500 μL of PBS. Each of 
the 7 monoclonal antibodies (anti-CD45-PE-CY7, anti-
CD3-FITC, anti-CD3-PerCP, anti-CD19-PE, anti-CD56-
PerCP, anti-CD4-PE, and anti-CD8-PerCP) was mixed with 
50 μL of microbead mixture in 7 separate tubes and left in 
the dark for 30 min. The tubes were washed twice with PBS, 
resuspended in 500 μL of PBS, and then analyzed using the 
same method and instrument settings as those used for 
analysis of the blood samples. The calibration curve of the 
MFI for each antibody to the ABC values was set using the 
MFI values of the 5 microbead populations and the Quick-
Cal program (www.bangslabs.com/products/quickcal). The 
ABC of each antigen in each cell population was calculated 
using these calibration curves (Fig. 1). 
3. Comparative quantitative analysis of CD3 antigen 
  expression on T lymphocyte subsets
The method used to label the cells and the flow cytometry 
settings were the same as described above. The calibration 
curve for the MFI values of the anti-CD3 antibody were set 
Fig. 2. Peripheral blood leukocytes after staining with anti-CD45 showing discrete granulocyte (P1), monocyte (P2), and lymphocyte (P3) populations according 
to the level of CD45 expression (A) FSC and SSC on the scattergrams (B) The lymphocyte subsets are separated using antibodies to surface antigens. CD3+CD56- T 
cells (gray) are plotted in the P4 region. CD3+CD56+ NKT cells (green) and CD3-CD56+ NK cells (blue) are plotted in the P5 and P2 regions, respectively (C) 
CD19+ B cells (red) are plotted in P3 region (D) Evidence for different CD45 expression (E) and FSC levels (F) CD3+CD56+ NKT cells (green) showed the highest 
CD45 and FSC expression levels. The CD3-CD56+ NK cells (blue) showed high level of FSC also.
Abbreviations: CD, cluster of differentiation; FSC, forward scatter; SSC, side scatter; NKT, natural killer T cell; NK, natural killer cell.
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as described above. The ABC values of CD3 on the 3 T lym-
phocyte subsets (CD3+CD4+, CD3+CD8+, and CD3+ 
CD56+) were calculated using these calibration curves.
4. Statistical analysis
The Kruskal-Wallis test was used to compare the values 
of CD45 ABC, FSC, and SSC on the cell populations. Two 
lymphocyte subsets were compared via a Wilcoxon singed 
rank sum test. The correlation between CD45 ABC, FSC, 
and SSC in all cell groups was evaluated using Pearson’s 
correlation test. P values of less than 0.05 were considered 
statistically significant.
RESULTS
1. CD45 expression, FSC, and SSC values in leukocyte 
  subpopulations
The expression of CD45 was the highest on lymphocytes 
(279,369±101,409), intermediate on monocytes (52,398± 
15,192), and the lowest on granulocytes (26,890±7,856). 
The expression levels differed significantly from one another 
(P=0.001). The FSC was highest in monocytes (134,035± 
5,877), intermediate in granulocytes (126,370±2,631), and 
lowest in lymphocytes (82,680±2,430). These values also 
differed significantly from one another (P=0.001). 
The SSC was highest in granulocytes (167,548±15,996), 
intermediated in monocytes (67,523±3,411), and lowest in 
lymphocytes (17,777±1,086). Again, these values differed 
significantly from one another (P=0.001).
2. CD45 expression, FSC, and SSC values on lymphocyte 
  subsets
The expression of CD45 and the FSC and SSC values for 
each lymphocyte subset are shown in Table 2 and Fig. 2. 
The pattern of CD45 expression on each lymphocyte subset 
was same in all 14 subjects. CD45 expression on the lym-
phocyte subsets from the highest to the lowest was 725, 
368±42,763 on NKT cells, 674,030±48,187 on Ts cells, 
588,750±48,090 on NK cells, 580,211±29,168 on Th cells, 
and 499,436±21,737 on B cells. The Th cells and NK cells 
expressed similar levels of CD45 (P=0.502).
The FSC was the highest in NKT cells, the next highest in 
NK cells, and the lowest in Th cells. The FSC in Ts cells and 
B cells was similar (P=0.589) (Fig. 2). 
The SSC was the highest in NKT cells, and the next high-
est in NK cells, followed by Ts cells, B cells, and Th cells in 
Table 3. Correlation among CD45, FSC, and SSC (P value) in lymphocytes 
evaluated via Pearson’s correlation test 
Parameter FSC SSC
CD45 0.256 0.268
(<0.001) (<0.001)
FSC 0.911
(<0.001)
Bold type: P value <0.05.
Abbreviations: CD, cluster of differentiation; FSC, forward scatter; SSC, side scatter.
Table 2. Expression level of CD45 and forward and side scatter values for each lymphocyte subset. Two lymphocyte subsets were compared via Wilcoxon singned 
rank sum test (P values)
Cell type Immuno-
phenotype
CD45
mean ABC±SD
FSC
mean channel value±SD
SSC
mean channel value±SD
CD3
mean ABC±SD
NKT CD3+CD56+ 725,368±42,763
(vs. NK: <0.001
Ts: <0.001
Th: <0.001 
B: <0.001)
97,814±3,694
(vs. NK: <0.001
Ts: <0.001 
Th: <0.001
B: <0.001)
23,340±907
(vs. NK: 0.048
Ts: <0.001 
Th: <0.001
B: <0.001)
39,947±3,344
(vs. Ts: <0.001
Th: 0.470)
NK CD3-CD56+ 588,750±48,090
(vs. Ts: 0.001 
Th: 0.221 
B: <0.001)
90,602±3,825
(vs. Ts: <0.001
Th: <0.001
B: <0.001)
22,519±1,408
(vs. Ts: <0.001
Th: <0.001 
B: <0.001)
Ts CD3+CD8+ 674,030±48,187
(vs. Th: <0.001
B: <0.001)
83,582±2,713
(vs. Th: <0.001 
B: 0.683)
18,906±1,159
(vs. Th: <0.001
B: <0.001)
32,868±1,768
(vs. Th: <0.001)
Th CD3+CD4+ 580,211±29,168
(vs. B: <0.001)
79,642±1,531
(vs. B: 0.002)
16,116±744
(vs. B: 0.002)
38,757±3,344
B CD19+ 499,436±21,737 84,188±3,730 17,110±1,147
Bold type: P value <0.05.
Abbreviations: CD, cluster of differentiation; ABC, antibody-binding capacity; NKT, natural killer T cell; NK, natural killer cell; Ts, cytotoxic/suppressor T cell; Th, helper T cell; FSC, for-
ward scatter; SSC, side scatter; B, B cell.152     www.kjlm.org
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descending order. The SSC values differed significantly be-
tween each of the lymphocyte subsets (P<0.05).
The CD45 expression level increased in proportion to the 
FSC (r=0.256, P=0.001) and the SSC (r=0.268, P=0.001). 
The FSC value was strongly associated with SSC (r=0.911, 
P=0.000) (Table 3).
3. Expression of CD3 on CD3+ lymphocyte subsets
CD3 expression was the highest in Th cells (38,757± 
3,344) and NKT cells (39,947±5,143) compared with Ts 
cells (32,868±1,768, P=0.001). We noted no significant dif-
ference between the Th and NKT cells (P=0.470) (Table 2).
DISCUSSION
Using CD45, SSC, and FSC, the leukocytes were well sep-
arated and could be gated to analyze the expression of other 
antigens. The FSC and SSC values were higher in mono-
cytes and granulocytes than in lymphocytes. The lympho-
cytes are classified into small lymphocytes and large lym-
phocytes according to morphology, and when flattened on 
glass slides, their sizes were 6-9 μm and 9-15 μm in diame-
ter, respectively [10, 11]. The medium or large-sized lym-
phocytes are known to be a mixed population consisting of 
NK cells and Ts cells. Although many NK cells show typical 
morphology of large granular lymphocytes, a significant 
proportion of NK cells are indistinguishable from other 
small lymphocytes, and may even be agranular [11]. In this 
study, the FSC was the highest in the NKT cells. The FSC in 
NK cells was second highest, and that in Th cells was the 
lowest. The FSC value in Ts cells and B cells was similar 
(P=0.589). 
The size of the B lymphocytes increased when G0 phase 
transitioned to G1 phase [12, 13]; however, no difference in 
cell size was observed between young and senescent T cells 
[14]. In this study, the circulating lymphocytes showed cha-
racteristic sizes according to subset. SSC was also the high-
est in the NKT cells, and SSC was proportional to FSC in 
each lymphocyte subset. SSC shows the degree of cell com-
plexity, and the granules in the large granular lymphocytes 
may have contributed to these high SSC values. 
The lymphocytes are characterized by the highest CD45 
expression and low SSC. In this study, the level of CD45 ex-
pression was significantly higher in the lymphocytes than in 
the monocytes and granulocytes. Because most B-cell lym-
phoma and leukemic cells have relatively high numbers of 
CD45 (100-300,000 antigenic sites per leukemic cell), it has 
been suggested that CD45 could be used to improve RIT 
targeting of both leukemias and lymphomas [6, 8, 9, 15]. 
The CD45 antigen has been shown to be superior to CD20 
for targeting in RIT [6, 8]. Cells harboring more CD45 anti-
gen would be effectively eradicated during RIT using an an-
tibody against CD45. Because there is only a weak correla-
tion between CD45, ABC, and FSC (r<0.3), the difference 
in CD45 expression among the lymphocyte subsets is not 
attributable to cell size, but rather the density of CD45 on 
the cell surface. Carulli et al. [16] previously employed the 
CD45 index [MFI of pathologic B lymphocytes/MFI of T 
lymphocytes (internal control)] in the differential diagnosis 
of various mature B cell lymphomas based on the lack of a 
difference in CD45 expression between normal B and T 
cells. In this study, CD45 expression varied among normal 
lymphocyte subsets and even within T cell subsets. Because 
there is interlaboratory variation in MFI values, the MFI 
cannot be used to compare the amount of surface antigens 
[17]. However, the antibody binding capacity of an antigen 
could be employed for interlaboratory comparison of the 
quantitative analysis of leukocyte membrane antigen ex-
pression via flow cytometry [18]. This study is, to the best of 
our knowledge, the first report on the ABC of CD45 anti-
gen on different lymphocyte subsets. We determined that 
NKT cells expressed the highest levels of CD45 antigen; 
therefore, this lymphocyte subset would be most pro-
foundly affected by RIT or PRIT. Monitoring this lympho-
cyte subset during and after RIT may prove helpful.
The CD3 antigen is a component of the T cell receptor 
(TCR) complex and is involved in the transduction of stim-
ulatory signals after antigen recognition [2]. It is expressed 
at high levels in mature T cells and is downregulated after 
antigen recognition and activation [19]. Th cells have been 
reported to express more CD3 antigen than Ts cells despite 
their smaller cell size [20-22]. In this study, the highest CD3 
expression was observed in Th cells and NKT cells. We 
noted no significant difference between the Th and NKT 
cells. Unlike antigens that stimulate only specific T cells, 
anti-CD3 antibody functions as a polyclonal activator of T 
cells. In addition, antibodies against CD3 proteins frequen-
tly independently stimulate T cell functional responses, 
which are identical to antigen-induced responses [2]. 
In summary, NKT cells express the highest levels of CD45 
antigen. Therefore, this lymphocyte subset would be most 
affected by RIT or PRIT. The monitoring of this lymphocyte 
subset during and after RIT is expected to prove helpful. 
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